NPI registry status
Active
2026 NPPES data Medical Oncology Physician NPI 1396056149 M.D.
Verify on CMS → Kelsey Klute, M.D.
Medical Oncology Physician in Omaha, Nebraska.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 4,028 in Medical Oncology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
542
Medicare Part D claims · 87 beneficiaries · Medical Oncology Physician avg: 732
Generic prescribing
82%
generic claims · 18% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$8.0K
11 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Kelsey Klute, M.D. filed 542 Medicare Part D claims in 2024 as a Medical Oncology Physician in Omaha, Nebraska, prescribing 82% generic.
- 542
- Part D claims, 2024
- 82%
- generic prescribing
- Likely
- board-certified (heuristic)
- ≥65th
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Kelsey Klute, M.D.
Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1396056149), first enumerated 06/27/2010.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 542 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Hospital affiliations
1 CMS Care Compare hospital affiliation on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- Reported
Industry payment transparency
$8.0K in reported industry payments (11 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1396056149 · Medical Oncology Physician
NPI-10 · ENUM-MID · TAX-NARROW · RX-LIGHT · BOOK-THIN · PHOTO-ENUM
- NPI-10 1396056149
- ENUM-MID 2010
- TAX-NARROW 4,028
- RX-LIGHT 542
- BOOK-THIN 9 in Nebraska
- PHOTO-ENUM Ariel Rischall · 2010
Kelsey Klute, M.D.'s Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2024, across all CMS prescribers nationally
542 ≥ 65th percentile 65% of 1,416,883 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2024
✓
Board certification likely (heuristic, not verified)
Kelsey Klute, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Kelsey Klute, M.D.?
Quality data not reportedPrimary specialty
Medical Oncology Physician
Medicare Part D claims
542 26% vs specialty avg
Specialty distribution in Nebraska
How Medical Oncology Physician compares to other specialties among Nebraska providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Medical Oncology Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1396056149 |
|---|---|
| Specialty | Medical Oncology Physician |
| Credentials | M.D. |
| Gender | Female |
| NPI Issued | 06/27/2010 |
Hospital and facility affiliations
Facilities where Kelsey Klute, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Unmc Physicians
Omaha, NE
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Kelsey Klute, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$8.0K
Largest payer
Ipsen Biopharmaceuticals, Inc
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Typical
Kelsey Klute, M.D. - brand share 18.0%
Medical Oncology Physician average
18% brand-name claims vs 82% generic, on 542 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
542
Total Claims
$423K
Total Drug Cost
87
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 735.633
- Total Day Supply
- 17,617
- Brand vs Generic
- 18% brand / 82% generic
- Brand Drug Cost
- $411K
- Generic Drug Cost
- $12K
- Opioid Claims
- 61 (11.3% rate)
- Antibiotic Claims
- 11
Patient Demographics
- Average Patient Age
- 70.9 years
- Avg HCC Risk Score
- 2.99
- Gender Split
- 52% female / 48% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Kelsey Klute, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2024
- Prochlorperazine M…
Prochlorperazine Maleate
57 claims
- Ondansetron Hcl
Ondansetron Hcl
51 claims
- Eliquis
Eliquis
45 claims
- Oxycodone Hcl
Oxycodone Hcl
34 claims
- Creon 18
Creon
18 claims
- Famotidine 17
Famotidine
17 claims
- Gabapentin 15
Gabapentin
15 claims
- Omeprazole 15
Omeprazole
15 claims
| Drug | Claims |
|---|---|
| Prochlorperazine Maleate | 57 |
| Ondansetron Hcl | 51 |
| Eliquis Apixaban | 45 |
| Oxycodone Hcl | 34 |
| Creon Lipase/Protease/Amylase | 18 |
| Famotidine | 17 |
| Gabapentin | 15 |
| Omeprazole | 15 |
| Duloxetine Hcl | 14 |
| Dexamethasone | 13 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Medical Oncology Physician Overview
How Kelsey Klute, M.D. fits within the Medical Oncology Physician landscape nationally.
4,028
Medical Oncology Physician Providers in US
53
States with Medical Oncology Physician
732
Avg Claims per Provider
Kelsey Klute, M.D.'s 542 claims are below the specialty average of 732.
Nationwide Medical Oncology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Klute, both outside Nebraska so the neighborhoods are not geographic containment.
Same NPPES enumeration year (2010)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Medical Oncology Physician Providers in Nebraska
Other clinicians with the same primary specialty enrolled in Nebraska, drawn from the same CMS NPPES roster as Klute.
One of 9 Medical Oncology Physician providers enrolled in Nebraska, 5 are shown here.
Dr. Eric Avery
M.D.
Lincoln, NE
Dr. David Garfield
M.D.
Ogallala, NE
Dr. Michael Haddadin
MD
Omaha, NE
Dr. Jack Lionberger
MD
Lincoln, NE
Dr. Madhu Midathada
MD
Lincoln, NE
Compare Medical Oncology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Kelsey Klute, M.D.'s specialty? ▼
Kelsey Klute, M.D. specializes in Medical Oncology Physician and practices in Omaha, Nebraska. Credentials: M.D..
How much does Kelsey Klute, M.D. prescribe under Medicare Part D? ▼
In 2024, Kelsey Klute, M.D. wrote 542 Medicare Part D claims totaling $423K in drug costs for 87 beneficiaries.
Where is Kelsey Klute, M.D. located? ▼
Kelsey Klute, M.D. is located at EMILE 42ND ST, Omaha, NE, 68198. Phone: (402) 559-5600.
What is Kelsey Klute, M.D.'s NPI number? ▼
Kelsey Klute, M.D.'s National Provider Identifier (NPI) is 1396056149, issued on 06/27/2010.
Does Kelsey Klute, M.D. prescribe more brand-name or generic drugs? ▼
Kelsey Klute, M.D.'s prescribing is 18% brand-name and 82% generic drugs by claim count, with $411K in brand drug costs.
Does Kelsey Klute, M.D. prescribe opioids? ▼
Yes, Kelsey Klute, M.D. had 61 opioid claims in 2024 with an opioid prescribing rate of 11.3%.
How many Medical Oncology Physician providers are there in the US? ▼
There are 4,028 Medical Oncology Physician providers across 53 states in the US. The average Medical Oncology Physician provider writes 732 Medicare Part D claims per year.
What drugs does Kelsey Klute, M.D. prescribe most often? ▼
Based on 2024 Medicare Part D data, Kelsey Klute, M.D.'s most frequently prescribed drugs include Prochlorperazine Maleate, Ondansetron Hcl, Eliquis. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Kelsey Klute, M.D. accept Medicare? ▼
Kelsey Klute, M.D. appears in CMS Medicare data with 542 Part D claims and 87 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Kelsey Klute, M.D.'s credentials? ▼
Kelsey Klute, M.D.'s NPI is 1396056149 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.